Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.33 |
| ▸ | TSHR | P16473 | 2/20 | 0.33 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.33 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.33 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.33 |
| ▸ | FFAR3 | O14843 | 1/20 | 0.30 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3659586 | 0.87 | TSHR (0.38) | TDP1TSHRCYP2D6CYP2C19HIF1A | |
| SCHEMBL13172935 | 0.75 | FFAR3 (0.37) | TDP1TSHRCYP2D6CYP2C19HIF1A | |
| SCHEMBL8462471 | 0.75 | TDP1 (0.33) | TDP1TSHRFFAR3ALDH1A1 | |
| SCHEMBL8744855 | 0.75 | — | — | |
| Alcohol SCHEMBL5806211 | 0.73 | TSHR (0.43) | TDP1TSHRCYP2D6CYP2C19HIF1A | |
| SCHEMBL13543296 | 0.73 | TSHR (0.33) | TDP1TSHRALDH1A1 | |
| SCHEMBL14102558 | 0.73 | TSHR (0.33) | TDP1TSHRALDH1A1 | |
| SCHEMBL105130 | 0.71 | TSHR (0.40) | TSHRCYP2D6CYP2C19HIF1AFFAR3 | |
| SCHEMBL276567 | 0.71 | — | — | |
| SCHEMBL184957 | 0.71 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20090222951-A1 | Method for producing polyunsaturated fatty acids in transgenic plants | BASF PLANT SCIENCE GMBH (DE) | 2009-09-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090222951-A1 | Method for producing polyunsaturated fatty acids in transgenic plants | FADS2, ELOVL3, SCD | TDP1 1255/4885TSHR 1505/4885CYP2D6 425/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.